Abstract
TRAF2 and TRAF3 genes of tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family are involved in diverse cell signaling, and function as both tumor suppressor gene and oncogene. Alterations of TRAF2 and TRAF3 in colon cancer (CC) along with their regional difference and microsatellite instability (MSI) are largely unknown. In the present study, we analyzed TRAF2 and TRAF3 frameshift mutations in 168 sporadic CCs (100 high MSI (MSI-H) and 68 microsatellite-stable (MSS) CCs). We identified TRAF2 and TRAF3 frameshift mutations in 4 (4%) and 3 CCs (3%) with MSI-H, respectively, but none in 68 cases of MSS CCs. Of the 168 CCs, we analyzed the mutations in multi-regions for 39 CCs (16 MSI-H and 23 MSS CCs), and discovered that 12.5% (2/16) and 6.3% (1/16) of MSI-H CCs exhibited regional difference in TRAF2 and TRAF3 mutations, respectively. In the multi-region samples of 23 MSS CCs, neither TRAF2 nor TRAF3 frameshift mutation was found. In 40% of CCs, both TRAF2 and TRAF3 expressions were increased compared to normal colon cells. Our data indicate that TRAF2 and TRAF3 frameshift mutations and their regional difference as well as altered expressions are present in MSI-H CCs, which could contribute to MSI-H cancer development.
Highlights
There are six mammalian tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family proteins that possess approximately 150 amino acid TRAF domains
We analyzed the regional difference in the TRAF2 and TRAF3 mutations in 92 regions of 16 CCs by Sanger sequencing as well as by single strand conformation polymorphism (SSCP), and no additional mutation was detected by the Sanger sequencing
We attempt to address following questions whether: 1) CCs harbor TRAF2 and TRAF3 frameshift mutations in MSIH-specific manner: 2) there is any regional difference in TRAF2 and TRAF3 frameshift mutations and 3) there are any expressional alterations of TRAF2 and TRAF3 in CCs
Summary
There are six mammalian tumor necrosis factor receptor (TNF-R)-associated factor (TRAF) family proteins that possess approximately 150 amino acid TRAF domains. TRAFs behave as adaptor proteins for many receptors, including TNF-R, NOD-like receptors, CD40 and toll like receptor (TLR) that mediate interactions between the receptors and downstream effector molecules, including IRAKs, RIP1, RIP2, TAK1, MEKK1 and ASK1 [1,2,3,4,5]. TRAFs (TRAF2, 3, 5 and 6) work as E3 ubiquitin ligases to regulate downstream signaling [4]. TRAFs function as both adaptor protein and E3 ubiquitin ligase to regulate receptor signaling in immune responses as well as other biological processes, including immune response, cell death and survival, development, and thrombosis [4]. TRAFs are known to be involved in the pathogenesis of many human diseases, including cancers [1, 2, 5]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.